companydata.dkcompanydata.dk

APO PHARM ApS: Financial statements 2019

CVR: 15226072

Source: annual report 2019, Danish Business Authority

01/07/2018 – 30/06/2019

APO PHARM ApS (CVR 15226072) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,798,685 and a net result of DKK 748,302 compared with DKK 66,213 the year before. That is an increase of 54.3% compared with the year before. Equity in the 2019 report amounted to DKK 1,093,397. The solvency ratio was 50.4%. The company had 5 employees in the financial year.

Gross Profit
DKK 1,798,685
Profit/Loss
DKK 748,302
Equity
DKK 1,093,397
Total Assets
DKK 2,169,246
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.8 mio.748 t.1.1 mio.5
2018-1.2 mio.66 t.345 t.5
2017-1 mio.52 t.279 t.-
2016-939 t.54 t.227 t.-
2015-945 t.2 t.173 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Marthine Overgaard Bertelsen joins the board of APO PHARM ApSFeb 27, 2019

As of February 27, 2019, Marthine Overgaard Bertelsen has joined the board of directors of APO PHARM ApS.

About APO PHARM ApS

APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VITALISTEN ApS. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.

Source: annual report 2025, Danish Business Authority